Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1997-11-17
2000-10-17
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241851, 4241931, 4241941, 4241981, 530850, 530300, 530313, 530326, 530327, 530328, 530329, 530810, 530827, 530852, 530853, 530854, 514 2, 514800, 930110, 930130, A61K 3800, A61K 3900, A61K 39385, A61K 3938
Patent
active
061327204
ABSTRACT:
Immunogenic compositions capable of generating an immune response in mammals against GnRH are disclosed. The immunogenic compositions are effective in methods of treating gonadotropin and gonadal steroid hormone dependent diseases and immunological contraception of mammals.
REFERENCES:
patent: 3963691 (1976-06-01), Hoffman et al.
patent: 4201770 (1980-05-01), Stevens
patent: 4302386 (1981-11-01), Stevens
patent: 4384995 (1983-05-01), Stevens
patent: 4526716 (1985-07-01), Stevens
patent: 4608251 (1986-08-01), Mia
patent: 4618598 (1986-10-01), Conn
patent: 4676981 (1987-06-01), Silversides
patent: 4691006 (1987-09-01), Stevens
patent: 4780312 (1988-10-01), Talwar
patent: 4795634 (1989-01-01), Grimes et al.
patent: 4879112 (1989-11-01), Silversides
patent: 4975420 (1990-12-01), Silversides
patent: 5023077 (1991-06-01), Gevas et al.
patent: 5036047 (1991-07-01), Mia
patent: 5109026 (1992-04-01), Hoskinson
patent: 5204108 (1993-04-01), Illum
patent: 5324512 (1994-06-01), Ladd et al.
patent: 5378688 (1995-01-01), Nett et al.
patent: 5403586 (1995-04-01), Russell-Jones
patent: 5413990 (1995-05-01), Haviv et al.
patent: 5484592 (1996-01-01), Meloen et al.
patent: 5488036 (1996-01-01), Nett et al.
patent: 5506207 (1996-04-01), Rivier
patent: 5508383 (1996-04-01), Sauer et al.
patent: 5557033 (1996-09-01), Halawani
patent: 5607676 (1997-03-01), Gevas et al.
patent: 5609870 (1997-03-01), Gevas et al.
patent: 5622702 (1997-04-01), Gevas et al.
patent: 5633248 (1997-05-01), Kato et al.
patent: 5648340 (1997-07-01), Barnea
patent: 5661126 (1997-08-01), Donahoe et al.
patent: 5684145 (1997-11-01), Vander Zee et al.
patent: 5688506 (1997-11-01), Grimes et al.
patent: 5759551 (1998-06-01), Ladd et al.
patent: 5785970 (1998-07-01), Gevas et al.
patent: 5843446 (1998-12-01), Ladd et al.
Fraser, H.M. "Effects of antibodies to leutenizing hormone releasing hormone on reproductive functions in rodents", in Imm. Horm. Repr. Res., Nieschlag ed., pp. 107-117, 1975.
Stevens et al. "The identification of peptide sequences of human chorionic gonadotropin containing a conformational epitope", Imm. Set. 12: 11-18, 1986.
Conn, et al. "Gonadotropin-releasing hormone and its analogues", New Eng. J. Med. 2: 93-103, 1991.
McLachlan, et al. "Clinical aspects of LHRH analogues in gynecology: a review", J. Obs. Gyn. 93: 431-454.
Fraser, H.M. "Physiological effects of antibody to leuteinising hormone releasing hormone", in Physiological Effects of Immunity Against Reproductive Hormones, Edwards and Johnson, Eds. Cambridge Univ. Press, pp. 137-165, 1976.
Johnson, et al. "The regulation of gonadal function in essential reproduction", 3.sup.rd Ed., pp. 101-154, 1988.
Science and Technology, "Clipping the stork's wings", The Economist, pp. 73-78, Jan. 9, 1993.
Fraser, H.M. "Active immunization of stumptailed macaque monkeys against luteinizing hormone releasing hormone, and its effects on menstrual cycles, ovarian steroids and positive feedback", J. Rep. Imm. 5: 173-183, 1983.
Jeffcoate, et al. "Anti-RH Sera in the investigation of reproduction", in Physiological Effects of Immunity Against Reproductive hormones, Edwards and Johnson eds. Cambridge Univ. Press, pp. 121-136, 1976.
Singh et al. "The dominant role of amide group at C-termians for recognition of antibody" J. Ster Biochem 23: 801-2 (1985).
Filicori, M. et al. "GnRH agonists and antagonists, current clinical status", Drugs, 35: 63-82, 1988.
Burgus, et al. "GnRH agonists and antagonists, current clinical status" Drugs 35: 63-82 (1988).
Marini, et al. "A simple method for increasing hapten . . . " J. Immuno. 120: 57-63 (1989).
Ladd, A. "Progress in the development of anti-LHRH vaccine", Am. J. Reprod. Immunol. 29: 189-194, (1993).
Talwar, et al. "Recent development in immunocontraception", Am. J. Obstet. Gynocol. 157: 1075-1078, (1987).
Talwar, et al. "A birth control vaccine is on the horizon for family planning", Ann. Med. 25: 207-212, (1993).
Thau, R. "Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications", Scand. J. Immunol. 36: 127-130, (1992).
Winkel, post graduate Med. 95(6): 111-118 (May '94).
Jung et al. J. Cath. Med. Cell 43 (1): 161-70 (1990) (Abstract).
Dutta et al. Pharm. Med. 7(1): 9-28 (1993).
Tenover et al. J. Clin. Endocrinal. Metabol. 71/4:881-888 (1996).
Kaetsu et al. "Biodeg adable implant composites for local therapy" J. of Controlled Release 6 (1987) 249.
Milanovic et al "Effect of treatment with LMRH analogs containing . . . " J. Cancer Res. Ain-Oncol. 119 (1993) 273-278.
Vincze, B. et al.. "In Vivo Studies of the new gonadotropin-releasing hormone antagonist . . . " Cancer Detection and Prevention 20 (1996) 153-9.
Sad, S. et al. "Synthetic gonadotropin-releasing hormone . . . " Vaccine 11 (1993) 1145.
Rekasi et al. "Effect of Ruteinizing hormone-releasing hormone . . . " Endo 132 (1991) 1991-2000.
Palyi, I. et al. "Effect of gonadotropin-releasing hormone analysis and . . . " Cancer Detection and Prevention 20 (1996) 146-152.
Grimes Stephen
Scibienski Robert
Aphton Corp.
Minnifield Nita
LandOfFree
Immunogens against gonadotropin releasing hormone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogens against gonadotropin releasing hormone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogens against gonadotropin releasing hormone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-465715